China Pharma Holdings (CPHI) Research & Development (2013 - 2026)
China Pharma Holdings (CPHI) reported Research & Development of $83762.0 for Q1 2026, up 183.1% on a YoY basis from $29587.0 in Q1 2025, and down 55.92% quarter-over-quarter from $190041.0 in Q4 2025.
China Pharma Holdings (CPHI) Research & Development (2013 - 2026) Analysis & Trends
China Pharma Holdings has reported Research & Development for 14 years, with the latest figure at $83762.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 183.1% year-over-year to $83762.0; the trailing twelve-month figure through Mar 2026 stood at $335076.0 (up 18.79% YoY), and the FY2025 full-year result was $280901.0, down 1.07% from the prior year.
- Research & Development for Q1 2026 stood at $83762.0, down from $190041.0 in the prior quarter.
- The five-year high for Research & Development was $190041.0 in Q4 2025, with the low at $547.0 in Q4 2024.
- Historically, Research & Development has averaged $63208.4 across 5 years, with a median of $40321.0 in 2025.
- Annual changes were most pronounced in 2024 — Research & Development plunged 99.63% — and 2025, when it soared 34642.41%.
- China Pharma Holdings' Research & Development stood at $27999.0 in 2022, then soared by 426.99% to $147552.0 in 2023, then sank by 99.63% to $547.0 in 2024, then soared by 34642.41% to $190041.0 in 2025, then plunged by 55.92% to $83762.0 in 2026.
- The last three Research & Development figures came in at $83762.0 (Q1 2026), $190041.0 (Q4 2025), and $40321.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | 83,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,762.00 |
| Dec 31, 2025 | 190,041.00 |
| Sep 30, 2025 | 40,321.00 |
| Jun 30, 2025 | 20,952.00 |
| Mar 31, 2025 | 29,587.00 |
| Dec 31, 2024 | 547.00 |
| Sep 30, 2024 | 87,610.00 |
| Jun 30, 2024 | 164,334.00 |
| Mar 31, 2024 | 31,451.00 |
| Dec 31, 2023 | 147,552.00 |
| Sep 30, 2023 | 45,773.00 |
| Jun 30, 2023 | 23,747.00 |
| Mar 31, 2023 | 23,008.00 |
| Dec 31, 2022 | 27,999.00 |
| Sep 30, 2022 | 88,747.00 |
| Jun 30, 2022 | 15,063.00 |
| Mar 31, 2022 | 54,049.00 |
| Dec 31, 2021 | 54,048.00 |
| Sep 30, 2021 | 21,374.00 |
| Jun 30, 2021 | 53,456.00 |